NANCY THOMPSON: Open Payments
NPI 1578843330 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,287 in 38 payments from 8 companies in 2025. Trend: 2023 $2,267 · 2024 $822 · 2025 $1,287
Food & beverage: $1,287
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $361 |
| E.R. Squibb & Sons, L.L.C. | 6 | $269 |
| Lundbeck LLC | 11 | $185 |
| Axsome Therapeutics, Inc. | 2 | $139 |
| ABBVIE INC. | 5 | $132 |
| Teva Pharmaceuticals USA, Inc. | 5 | $98 |
| Janssen Pharmaceuticals, Inc | 5 | $85 |
| Alkermes, Inc. | 1 | $18 |
Products named: COBENFY, ABILIFY MAINTENA, REXULTI, Auvelity, VRAYLAR, ABILIFY ASIMTUFII, UZEDY, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
